Cargando…

Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study

Detalles Bibliográficos
Autores principales: Schneider, L, Houssaini, A, Lambert, S, Peytavin, G, Agher, R, Chermak, A, Flandre, P, Calvez, V, Marcelin, AG, Ghosn, J, Katlama, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113030/
http://dx.doi.org/10.1186/1758-2652-13-S4-P29
_version_ 1782205872126033920
author Schneider, L
Houssaini, A
Lambert, S
Peytavin, G
Agher, R
Chermak, A
Flandre, P
Calvez, V
Marcelin, AG
Ghosn, J
Katlama, C
author_facet Schneider, L
Houssaini, A
Lambert, S
Peytavin, G
Agher, R
Chermak, A
Flandre, P
Calvez, V
Marcelin, AG
Ghosn, J
Katlama, C
author_sort Schneider, L
collection PubMed
description
format Online
Article
Text
id pubmed-3113030
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130302011-06-13 Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study Schneider, L Houssaini, A Lambert, S Peytavin, G Agher, R Chermak, A Flandre, P Calvez, V Marcelin, AG Ghosn, J Katlama, C J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113030/ http://dx.doi.org/10.1186/1758-2652-13-S4-P29 Text en Copyright ©2010 Schneider et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Schneider, L
Houssaini, A
Lambert, S
Peytavin, G
Agher, R
Chermak, A
Flandre, P
Calvez, V
Marcelin, AG
Ghosn, J
Katlama, C
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
title Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
title_full Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
title_fullStr Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
title_full_unstemmed Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
title_short Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
title_sort week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced hiv-1 patients with virological success: dardar study
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113030/
http://dx.doi.org/10.1186/1758-2652-13-S4-P29
work_keys_str_mv AT schneiderl week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT houssainia week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT lamberts week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT peytaving week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT agherr week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT chermaka week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT flandrep week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT calvezv week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT marcelinag week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT ghosnj week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy
AT katlamac week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy